Baptist Health Doc-to-Doc

Epilepsy care has evolved dramatically in recent years. Advances in diagnostics, surgical techniques, and neuromodulation are transforming how physicians treat patients with drug-resistant epilepsy.In this episode of Baptist Health Doc to Doc, Neurosurgeon and System Chief Executive of Baptist Health Brain & Spine Care and Chief Medical Executive of Miami Neuroscience Institute, Dr. Michael McDermott is joined by epilepsy experts, Dr. Aviva Abosch, deputy director of the Institute as well as director of epilepsy surgery and co-director of functional neurosurgery and Dr. Luis Tornes, neurologist and the director of the epilepsy program at the Miami Neuroscience Institute at Baptist Health South Florida.Together they explore how multidisciplinary teams diagnose epilepsy, evaluate patients for surgery, and use advanced technologies such as responsive neurostimulation, deep brain stimulation, and stereotactic EEG to improve outcomes.Topics include:·         How physicians specialize in epilepsy care·         The role of epilepsy monitoring units·         Surgical approaches for drug-resistant epilepsy·         Neuromodulation technologies like RNS, DBS, and VNS·         Emerging therapies including biologics and cellular treatmentsThis conversation offers a deeper look at how neuroscience innovation is improving quality of life for patients living with epilepsy.Learn more about the Epilepsy Program at Miami Neuroscience Institute: baptisthealth.net/neuroscienceHost:Michael McDermott, M.D.Neurosurgeon & Chief Medical Executive Baptist Health Miami Neuroscience InstituteChair, Neurosciences, FIUGuests:Aviva Abosch, M.D.Neurosurgeon & Deputy Director Baptist Health Miami Neuroscience Institute Luis Tornes, M.D. Neurologist & Director of the Epilepsy Program Baptist Health Miami Neuroscience InstituteIf you found this episode helpful, you may also enjoy:The Pituitary Playbook - Functional Tumors, Vision Risks & Endoscopic SolutionsEvolving Advances in Brain Tumor Care TMS: Making Waves with Treatment Resistant Depression

In this episode of Baptist Health Doc to Doc, Dr. John Diaz and Dr. Mehran Habibi discuss how artificial intelligence, robotic surgery, precision medicine, and targeted therapies are transforming breast cancer and gynecologic oncology in 2026.Topics include:- AI-assisted breast imaging and surgical planning- Robotic hysterectomy and minimally invasive cancer surgery- De-escalation of sentinel lymph node biopsy- Circulating tumor DNA (MRD) and treatment personalization- Antibody-drug conjugates (ADCs)- Oral SERDs and evolving endocrine therapy- HPV vaccination and cervical cancer preventionAs cancer care moves from radical procedures to optimized, personalized treatment, innovation is improving outcomes while reducing recovery time and surgical risk.Presenters:John P. Diaz, M.D., FACOG, FACSChief of Gynecologic OncologyBaptist Health Miami Cancer InstituteMehran Habibi, M.D., MBADeputy Chief of Breast SurgeryBaptist Health Cancer Care

Join Joseph Panoff, M.D., radiation oncologist at Baptist Health Miami Cancer Institute, and Youssef Zeidan, M.D., radiation oncologist at Lynn Cancer Institute, for an in-depth physician-to-physician discussion on modern breast cancer radiation therapy.They explore how photon-based radiation has evolved over the last two decades—from early planning techniques to today’s highly conformal approaches that improve precision while reducing toxicity. The conversation also examines emerging comparisons between proton and photon therapy, including how each modality impacts cardiac exposure, skin toxicity, and long-term survivorship considerations.This episode highlights the importance of individualized treatment planning, the growing focus on safely reducing unnecessary treatment, and how collaboration across leading cancer institutes is shaping the future of radiation oncology.Host:Joseph Panoff, M.D.  Radiation OncologistBaptist Health Miami Cancer InstituteGuest:Youssef Zeidan, M.D.  Radiation OncologistLynn Cancer Institute

In this episode of Baptist Health’s Doc-to-Doc, we take a closer look at one of the most concerning trends in oncology — the rise of breast cancer among younger women.Dr. Anastasia Tousimis, Deputy Director of Baptist Health Cancer Care, sits down with Dr. Louise Morrell, Chief Medical Executive of Lynn Cancer Institute, to discuss what’s driving this gradual increase and how clinicians can better identify, screen and support high-risk patients.Together, they explore the latest research on environmental and genetic factors, screening challenges in dense breasts and how AI is transforming early detection. The discussion also highlights fertility preservation and the importance of multidisciplinary care for young women navigating a diagnosis.From radiation exposure to BRCA mutations, this conversation connects cutting-edge science with compassionate care — offering practical insight for clinicians and reassurance for patients alike.Host:Anastasia Tousimis, M.D.Deputy Director, Baptist Health Cancer CareMedical Director, Al and Jane Nahmad Women's Cancer Center, Baptist HealthExpert:Louise Morrell, M.D.Chief Medical ExecutiveEugene M. & Christine E. Lynn Cancer InstituteBaptist Health Boca Raton Regional Hospital 

In this Baptist Health Doc-to-Doc episode, Dr. Michael McDermott, Chief Medical Executive of Baptist Health Miami Neuroscience Institute sits down with Dr. Evan Bander, Neurosurgeon & Co-Director of  the Pituitary Tumor Program at the Baptist Health Miami Neuroscience Institue, to unpack the complexities of the body’s “master gland.” Together, they explore how pituitary tumors are diagnosed and treated, the difference between functional and non-functional adenomas and why minimally invasive endoscopic surgery is changing outcomes. You’ll hear about early warning signs such as vision changes, the importance of a multidisciplinary pituitary team and the latest surgical and radiosurgical approaches. Whether you’re a clinician managing these conditions or a patient seeking to better understand them, this discussion sheds light on earlier detection, safer surgery and lifelong follow-up.👉 If you are a neurosurgeon, endocrinologist, or ENT specialist managing pituitary disorders, this conversation will help sharpen your clinical edge.👀 Patients and families can also learn what to look for and what today’s treatment options mean for long-term health.🔔 Subscribe for more expert insights: @BaptistHealthSFHost:Michael McDermott, M.D.Chief Medical Executive and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience at Miami Neuroscience Institute, as well as Chair of the Department of Neurosciences at Florida International University Herbert Wertheim College of MedicineExpert:Evan Bander, M.D.Neurosurgeon & Co-Director of the Pituitary Tumor ProgramBaptist Health Miami Neuroscience Institute

In this episode of Baptist Health's Doc-to-Doc, we explore the evolving landscape of arrhythmia care with host Tom Nguyen, M.D., Chief Medical Executive of Baptist Health Heart & Vascular Care, Director of Minimally Invasive Surgery, and Barry T. Katzen Endowed Chair at Miami Cardiac & Vascular Institute, and Professor and Chair of the Department of Cardiovascular Sciences at Florida International University Herbert Wertheim College of Medicine. Electrophysiologist, Mario Pascual, M.D., and Cardiothoracic surgeon, Bryon Tompkins, M.D. of Baptist Health Heart & Vascular Care.Together they discuss why early referral changes AFib outcomes, how hybrid epicardial-endocardial ablation strategies improve rhythm durability and the role of left atrial appendage management in reducing stroke risk. The conversation also highlights modern pacing approaches to protect heart function, the importance of timely device infection management and the emerging impact of Al and robotic mapping on electrophysiology and surgical collaboration.👉 If you are a cardiologist, electrophysiologist or cardiac surgeon navigating the complexity of rhythm disorders, this conversation will help sharpen your clinical edge.🔔 Subscribe for more expert insights: @BaptistHealthSFTom Nguyen, M.D.Cardiac Surgeon & Chief Medical ExecutiveBaptist Health Heart & Vascular CareChair, Cardiovascular Sciences, FIUMario Pascual M.D.ElectrophysiologistBaptist Health Heart & Vascular CareBryon Tompkins, M.D.Cardiac SurgeonBaptist Health Heart & Vascular Care

In this episode of Doc to Doc, we explore groundbreaking advances in the treatment of blood cancers with two of the field’s leading experts:Dr. Guenther Koehne, Deputy Director and Chief of Blood and Marrow Transplant, Hematologic Oncology and Benign Hematology, and Dr. Firas El Chaer, Chief of Leukemia Services and Medical Director of Infusion — both from Baptist Health Miami Cancer Institute.From precision-targeted therapies and measurable residual disease (MRD) to cutting-edge immunotherapies like (CAR) T-cell therapy, BiTEs, and NK-cell approaches — we cover the evolving tools that are reshaping treatment protocols across leukemia, myeloma, MDS, and lymphoma.Topics Covered:✅ MRD-guided treatment decisions✅ Overcoming drug resistance with combination strategies✅ Targeted therapies for actionable mutations✅ The expanding role of CAR T, BiTEs, and NK cells✅ Clinical application and access at Baptist HealthIf you're an oncologist, hematologist, or transplant specialist navigating the complexity of hematologic malignancies — this conversation will help sharpen your clinical edge.🔔 Subscribe for more expert insights: @BaptistHealthSF📍 Learn more at MiamiCancerInstitute.com

Why do thyroid cancers demand a more nuanced approach, despite high survival rates? In this episode of Doc to Doc, Dr. Meghan Crawley, head and neck surgical oncologist at Miami Cancer Institute, joins Dr. Rachel Slotcavage, endocrine surgeon at Lynn Cancer Institute, to explore what makes thyroid cancers so unique and how treatment approaches are evolving. From surgery and RAI therapy to targeted therapies, immunotherapy, and biomarker-driven decisions, this conversation takes a closer look at how precision medicine is shaping the future of thyroid cancer care—and what every clinician should consider in today’s multidisciplinary landscape.Meghan Crawley, M.D. Head and Neck Surgical Oncologist with Baptist Health Miami Cancer Institute Rachel Slotcavage, M.D. Endocrine surgeon with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital

What happens when landmark trials challenge long-standing surgical standards?In this episode of Doc to Doc, Dr. Thomas Morrissey, director of gynecologic oncology at Lynn Cancer Institute, joins Dr. Ryan Kahn, gynecologic oncologist at Miami Cancer Institute, to explore how data from pivotal studies like TRUST, SHAPE, and MIRASOL are redefining treatment decisions in gynecologic cancer.From respectability scoring to the evolving role of checkpoint inhibitors and targeted antibody-drug conjugates, this conversation highlights a bold shift toward more personalized, evidence-based care, and what every clinician should know in this new era.Thomas Morrissey, M.D., Director of Gynecologic Oncology with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. Ryan Kahn, M.D.Gynecologic OncologistBaptist Health Miami Cancer Institute

What happens when we stop gatekeeping genetic testing and offer it universally? In this episode of Doc to Doc, Dr. Arelis Martir Negron, medical geneticist at Miami Cancer Institute, joins Dr. Venkatappa to explore how the field of cancer genetics is transforming — and what every clinician should know. From BRCA1 and BRCA2 to multi-gene panels and AI-powered risk stratification, testing this conversation covers the past, present, and bold future of universal germline testing.Host:Siddhartha Anantha Venkatappa, M.D., Oncologist/Hematologist at Baptist Health Miami Cancer InstituteGuest:Arelis Martir Negron, M.D., FAMG, Medical Geneticist at Baptist Health Miami Cancer Institute

Brain tumors remain among the most complex and challenging conditions we confront. There are over 120 histologically distinct tumor types, with survival outcomes varying drastically depending on molecular profile and location. As a result, the need for nuanced, multidisciplinary care has never been more evident.While advances in neuroimaging, genomic profiling, and immunotherapy have shifted paradigms, many patients still face limited treatment options and high morbidity.During Brain Tumor Awareness Month, we’re reinforcing our shared commitment to early detection, clinical trials, patient-centered research, and the ethical complexities of surgical and systemic interventions. From glioblastomas to benign meningiomas, and from pediatric to geriatric cases, we’ll be spotlighting emerging data, revisiting case studies, and discussing how to translate innovation into outcomes. Presenters:Manmeet Ahluwalia, M.D., MBA, FASCO, Chief Scientific Officer, Chief of Medical Oncology, Deputy Director and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer InstituteMinesh P. Mehta, M.D., Chief of Radiation Oncology, Deputy Director and John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute 

Thanks for joining us today for this in-depth discussion on head and neck cancers, including oral cancer. In this episode, we explore the complexities of diagnosing, treating, and managing these challenging malignancies. With advancements in disease biology, artificial intelligence integration, robotic surgery, and biomarker-driven therapies, the treatment landscape has evolved, offering more personalized care that enhances survival rates and preserves function and quality of life. However, there’s still much work to be done in improving outcomes for patients. Tune in for a deeper understanding of these innovations and their impact on oncology. Presenters:Geoffrey Young, M.D., Chief of Head and Neck Cancer Surgery at Baptist Health Miami Cancer InstituteAlessandro Villa, D.D.S., Chief of Oral Medicine, Oral Oncology and Dentistry at Baptist Health Miami Cancer Institute

Pancreatic cancer has been a lethal malignancy for too long. Available cytotoxic therapies for advanced disease are modestly effective with a 5-year survival rate, less than 15%, but new modalities using ablative radiation therapy holds promise in improving outcomes. Reports of ablative radiation therapy for pancreatic cancer using the 0.35 Tesla, MR Linac have resulted in promising local control and overall survival with no severe toxicity in patients with locally advanced pancreatic cancer despite radio-sensitive organs adjacent to the target volumes. Global testing has found a wide variation in treatment planning protocols for pancreatic tumors with MR-guided SBRT on a 0.35 Tesla MR-Linac. Presenters: Kathryn Mittauer, PhD, DABR, Senior Medical Physicist with Baptist Health Miami Cancer Institute & Associate Professor at Florida International University Herbert Wertheim College of Medicine. Adeel Kaiser, M.D., Board-certified radiation oncologist at Baptist Health Miami Cancer Institute and clinical associate professor at Florida International University Herbert Wertheim College of Medicine. 

Lung cancer has shown a decrease in incidence and mortality in recent decades; however, it remains one of the cancers with the highest incidence and still ranks first in cancer-related deaths in the United States. Advancements like molecular interpretation of lung cancer has substantially changed the classification and treatment of these tumors, becoming an essential component of pathologic diagnosis and oncologic therapy decisions. Through the recognition of novel biomarkers, such as epidermal growth factor receptor mutations and anaplastic lymphoma kinase translocations, it has been possible to identify subsets of patients who benefit from targeted molecular therapies.  We’re encouraging patients to learn more about their lung health by offering special pricing on lung screenings through the month of November. Patients without health insurance or whose insurance does not cover the test can receive a lung screening for $35. A prescription is required. This Lung Cancer Awareness Month, stay on top of your lung health by visiting BaptistHealth.net/LungScreening or call 833-596-2473.  Presenters:Manmeet Ahluwalia, M.D., MBA, FASCO, Chief Scientific Officer, Chief of Medical Oncology, Deputy Director and Fernandez Family Endowed Chair in Cancer Research with Baptist Health Miami Cancer Institute. Upal Basu Roy, Ph.D, MS. MPH, Executive Director of LUNGevity ResearcTop of Formh

Uterine Transposition: Transforming Gynecologic Cancer Care and Fertility Preservation Uterine transpositions represent a groundbreaking advancement in fertility preservation for women undergoing treatment for gynecologic cancers. Dr. John P. Diaz and Dr. Jean-Marie Stephan are at the forefront of this innovative surgery at Miami Cancer Institute, which involves temporarily relocating the uterus to shield it from the damaging effects of radiation and chemotherapy. By sharing their expertise and successful outcomes with the community, they aim to raise awareness about this life-changing procedure, offering hope to women who wish to preserve their fertility while battling cancer. Learn how both experts have worked with experts at MSK to innovate this surgery for two specific patients, and intend to for future patients to come. Presenters:John P. Diaz, M.D., Chief of Gynecologic Oncology at Baptist Health Miami Cancer Institute Jean-Marie Stephan, M.D., Gynecologic Oncologist at Baptist Health Miami Cancer Institute Click here to video of this podcast.

Aside from non-melanoma skin cancers, Prostate cancer, or PCa, is the most common cancer diagnosed for males in the United States and the second leading cause of cancer death for them. Its varying degrees of aggressiveness along with high incidence to mortality ratio, provide significant challenges for both patients and the medical community. However, the treatment landscape of PCa and its metastatic form is rapidly evolving and recent trials in patients with metastatic castration resistant prostate cancer are showing great promise.Presenters:Rohan Garje, M.D., Chief of Genitourinary Medical Oncology at Baptist Health Miami Cancer InstituteAdeel Kaiser, M.D., Board Certified Radiation Oncologist at Baptist Health Miami Cancer Institute

Minimally Invasive Spine Surgery (MISS) of the lumbar spine is a type of surgery that uses smaller incisions that standard lumbar spine surgery.  Minimally Invasive Spine Surgery can result in less pain, faster recovery, and less damage to nearby muscles and tissue.  The advent of interactive navigation and intraoperative imaging have become an important part of accurate, efficient, and safe spine surgery using minimally invasive techniques. Presenters: Michael McDermott, M.D., Chief Medical Executive at Baptist Health Miami Neuroscience Institute and the Irma & Kalman Bass Endowed Chair in Clinical Neuroscience Michael Gomez, M.D., Spinal Neurosurgeon and Director of Minimally Invasive Spine Surgery at Baptist Health Miami Neuroscience Institute at South Miami Hospital.

Inappropriate sinus tachycardia, also known as IST, is a condition of elevated sinus rate unassociated with known pathological, pharmacological, or physiological causes. Its diagnosis has been, in the past, missed or at times dismissed. It does not help that its definitions in current literature are inconsistent, and professional society consensus have had limited impact. Considering its broad setting of physiology, pathology, and uncertainties, the therapy for IST remains challenging. To date high rates of symptom recurrence, treatment failure, and complications have followed many therapies.  Although, not well accepted by guidelines, the main hope lies in ablation procedures. Unfortunately, the results of endocardial radiofrequency ablation have not been encouraging. Today we will explore the multiple aspects of IST and the treatment techniques surrounding it.  Presenters: Steven Hoff, M.D., a board-certified cardiac and thoracic surgeon at Baptist Health Miami Cardiac & Vascular Institute Mario Pascual, M.D., an electrophysiologist with Baptist Health Miami Cardiac & Vascular Institute specializing in diagnosing arrhythmias and treating heart rhythm disorders

We could not be more exhilarated about the research led by investigators at Baptist Health Miami Cancer Institute. Several of our physician-researchers presented their studies at this year’s ASCO annual meeting in Chicago. Join us as we highlight many of our findings, because many of these landmark studies are transforming care, extending lives, and improving the quality of life of our patients.  Presenters: Michael Zinner, M.D., Executive Medical Director of Baptist Health Miami Cancer Institute Manmeet Ahluwalia, M.D., Chief of Medical Oncology, Chief Scientific Officer, Deputy Director of Miami Cancer Institute, and Fernandez Family Foundation Endowed Chair in Cancer Research

Even with the success of reducing smoking, lung cancer remains the leading cause of cancer deaths worldwide for both men and women. In 2023, there were approximately 238,000 new lung cancers and 125,000 deaths in the United States alone. In recent decades, the evolution of robotic-assisted thoracic surgery has enhanced primary lung cancer treatment and postoperative outcomes. This, in combination with advances in immunotherapy and our understanding of cancer’s molecular biology, brings many tools to the battle against the leading cause of cancer deaths in the United States.  Join Dr. Mark Dylewski, chief of general thoracic surgery at Baptist Health, and Dr. Paul Kaywin, medical oncologist at Baptist Health Miami Cancer Institute, as they discuss advances in lung cancer treatment from a medical oncology and surgical perspective.   Mark Dylewski, M.D. Director of General Thoracic Surgery and Robotic Thoracic SurgeryChief of General Thoracic Surgery, Baptist Health Chairman of Thoracic Surgical Oncology, Miami Cancer Institute  Paul Kaywin, M.D. Medical Oncologist Miami Cancer Institute Baptist Health

Join Drs. Michael McDermott and Nir Lipsman as they discuss focused ultrasound in neuroscience, how it started and the clinical research that brings us to where we are today and what the future holds. Presenters: Michael McDermott, M.D.Chief Medical Executive, Baptist Health Miami Neuroscience Institute Irma & Kalman Bass Endowed Chair in Clinical NeuroscienceNir Lipsman, M.D.Harquail Chair in Neuromodulation, University of Toronto and Sunnybrook Health Sciences CentreDirector, Harquail Centre for Neuromodulation, Sunnybrook Michael McDermott, M.D., is a neurosurgeon and the chief medical executive of Baptist Health Miami Neuroscience Institute. He is a world-renowned leader in neurosciences and has clinical expertise in the field of meningioma surgery and Gamma Knife radiosurgery.   Nir Lipsman, M.D., is a neurosurgeon, scientist and Director of Harquail Centre for Neuromodulation at Sunnybrook and associate professor in the department of surgery at the University of Toronto.  Dr. Lipsman helped lead Canada’s first clinical trials of FUS in essential tremor and Parkinson’s disease, and is developing trials investigating FUS in obsessive-compulsive disorder, depression, and Alzheimer’s disease.

In the third and final episode of the series on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we will examine the advancements in left atrial appendage management and discuss what lies ahead in promising developments offering brilliant and never-imagined solutions.  Presenters: Steven Hoff, M.D., a board-certified cardiac and thoracic surgeon at Baptist Health Miami Cardiac & Vascular Institute. Dr. Hoff specializes in adult cardiac surgery. Mario Pascual, M.D., electrophysiologist with Baptist Health Miami Cardiac & Vascular Institute. He focuses on the heart’s electrical system and specializes in diagnosing and treating heart rhythm disorders, or arrhythmias. 

Join Michael McDermott, M.D., chief medical executive of Baptist Health Miami Neuroscience Institute, and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience, along with Manmeet Ahluwalia, M.D., MBA, FASCO, the chief of medical oncology, chief scientific officer & deputy director, and Fernandez Family Endowed Chair in Cancer Research at Baptist Health Miami Cancer Institute, as they discuss a prospective clinical trial on the use of low intensity focused ultrasound for non-small cell lung cancer brain metastases, gender distribution, previous treatment results, and overall survival. Presenters Michael McDermott, M.D.Chief Medical Executive, Miami Neuroscience InstituteIrma & Kalman Bass Endowed Chair in Clinical Neuroscience Manmeet Ahluwalia, M.D., MBA, FASCOChief of Medical Oncology, Chief Scientific Officer & Deputy Director,Fernandez Family Endowed Chair in Cancer Research Baptist Health Miami Cancer Institute

Join Tom C. Nguyen, M.D., chief medical executive, director of minimally invasive valve surgery of Baptist Health Miami Cardiac & Vascular Institute, and Barry T. Katzen Endowed Chair, along with Nish Patel, M.D., an interventional cardiologist and Director of the Structural Heart Program at Baptist Health Miami Cardiac & Vascular Institute, as they discuss the future of AI in modern-day medicine and within the field of Cardiology and Cardiothoracic Surgery. This episode explores AI innovation and how it’s becoming an essential medical tool in modern-day medicine. Join us as we explore how AI has assisted in becoming a promising tool for practicing physicians in surgery, research, the importance of staying current on all new technologies, and how we can incorporate them into our daily practices, which gives medicine the promise to save and enhance countless lives not only in our community but on a global scale.  Tom C. Nguyen, M.D., Chief Medical Executive, Barry T. Katzen Medical Director Endowed Chair and Director of Minimally Invasive Valve Surgery at Baptist Health Miami Cardiac & Vascular Institute Nish Patel, M.D., Director, Structural Heart Program at Baptist Health Miami Cardiac & Vascular Institute

 In the 2nd episode on atrial fibrillation with Dr. Steven Hoff and Dr. Mario Pascual, we are exploring surgical ablation, Endo/Epicardial Catheter approach for mapping and ablation of A-Fib. We will also visit the current oral anticoagulants and the Pre, Peri and Postprocedural usage of DOACs, NOACs and TSOAC. Guests: Steven Jeffrey Hoff, M.D., Cardiac and Thoracic Surgeon, Miami Cardiac & Vascular Institute Mario Ignacio Pascual, M.D., Electrophysiologist, Miami Cardiac & Vascular Institute

Join doctors Michael McDermott, M.D. and Rachel Rohaidy, M.D., as they discuss Transcranial Magnetic Stimulation (TMS). TMS is an innovative and promising treatment modality for patients with treatment-resistant depression and has evolved to a more refined technique with multiple diagnostic and therapeutical uses. Guests: Michael McDermott, M.D., FAANS, Chief Medical Executive, Miami Neuroscience Institute, Irma and Kalmam Bass Distinguished Clinical Professor & Endowed Chair in Clinical Neuroscience Chief of the Division of Neuroscience; and Professor Translational Medicine, Florida International University, Herbert Wertheim College of Medicine Rachel Rohaidy, M.D., Psychiatry, Baptist Health Miami Neuroscience Institute 

Join Baptist Health Miami Cardiac & Vascular Institute experts Jonathan Fialkow, M.D., FACC, Adedapo (Dapo) Iluyomade, M.D., and Sergiu Darabant, M.D. as they discuss how this development could revolutionize the approach to combating cardiometabolic diseases through targeting inflammation, and what it means for your patients. In this enlightening episode, we delve into the groundbreaking FDA approval of colchicine for the prevention of major adverse cardiovascular events. Join us as we explore the journey of this ancient remedy, traditionally used for gout, now emerging as a promising agent in cardioprotection. We dissect the pivotal clinical trials and evidence-based data that led to this landmark decision, shedding light on colchicine's mechanism of action and its potential role in reshaping preventive cardiology.  Guests: Jonathan Fialkow, M.D., FACC                          Chief Medical Executive for Population Health, Value and Primary Care Deputy Director of Miami Cardiac & Vascular InstituteChief of Cardiology, Baptist Hospital Adedapo (Dapo) Iluyomade, M.D., Preventive Cardiologist, Baptist Health Miami Cardiac & Vascular Institute Sergiu Darabant, M.D., Cardiologist, Baptist Health Miami Cardiac & Vascular Institute 

Young women with breast cancer represent a distinct demographic within the breast cancer population. In this insightful episode, Dr. Jane Mendez, Chief of Breast Surgery at Miami Cancer Institute, and Dr. Ana Sandoval Leon, medical oncologist specializing in breast cancer at Miami Cancer Institute, delve into the intricate world of breast cancer as it affects young women.Guests: Jane Méndez, M.D., FACS, Chief of Breast Surgery, Baptist Health Miami Cancer InstituteAna Sandoval Leon, M.D., medical oncologist specializing in breast cancer, Baptist Health Miami Cancer Institute 

Neuromodulation and Spinal Cord Stimulation is utilized to deliver precise electrical signals to the spinal cord to alter pain signal processing. In this podcast, Michael McDermott, M.D., Jason Liounakos, M.D., and Akshay Goyal, M.D. will explore the background of this process, ideal candidates, the future of this therapy, and much more. Join Miami Neuroscience Institute experts as they discuss neuromodulation of spinal cord function to ease pain-related symptoms. Guests: Michael McDermott, M.D., Chief Medical Executive, Baptist Health Miami Neuroscience Institute Jason Liounakos, M.D., Neurosurgeon and Director of Outpatient Spine Surgery, Baptist Health Miami Neuroscience Institute Akshay Goyal, M.D., Pain Management Physician, Baptist Health Miami Neuroscience Institute 

In this podcast, the first of 3 episodes on atrial fibrillation, Steven Hoff, M.D. and Mario Pascual, M.D. will explore the history of AFib from the invention of the ECG in the 20th century until pharmacologic meanderings of the past, such as aspirin and digoxin.  Join Baptist Health Miami Cardiac & Vascular Institute experts as they discuss Atrial Fibrillation and its history, innovation, and development that has brought us to where we are today. Guests: Steven Jeffrey Hoff, M.D., Associate Chief of Cardiac Surgery at Baptist Health Miami Cardiac & Vascular Institute Mario Ignacio Pascual, M.D., Medical Director of Electrophysiology and Arrhythmia Management, Baptist Health Miami Cardiac & Vascular Institute

Globally, the incidence of HPV-associated oropharyngeal cancer has increased over the past few decades, to a greater degree among young adults. Even more shocking is HPV-related oropharyngeal cancer has surpassed that of cervical cancers. Nearly 45,000 cancers are attributed to HPV infection in the United States annually, with almost half of these being oropharyngeal oriented.  Join Miami Cancer Institute experts as they discuss oropharyngeal and cervical cancer, preventative screenings, the HPV vaccine, and oral complications sometimes caused by cancer-related treatment. Guests: John Diaz, M.D., Chief of Gynecologic Oncology, Baptist Health Miami Cancer Institute Alessandro Villa, M.D., PhD, Chief of Oral Medicine, Oral Oncology and Dentistry, Baptist Health Miami Cancer Institute

Approximately 30,000 Americans suffer from a cerebral aneurysm rupture each year and the number of Americans affected by an aneurysm isn’t really known since many do not produce symptoms.  It is estimated that anywhere between 3 and 5 percent of Americans may have an aneurysm at some point in their lifetime.  Who is at risk, what causes a hemorrhage in the brain, and from a medical standpoint, what are the newest findings about cerebrovascular aneurysms? Join us as our experts discuss latest treatments, what to look out for and more on this episode of Baptist HealthTalk: Doc-to-Doc podcast.Guests:Michael McDermott, M.D., Chief Medical Executive, Miami Neuroscience Institute Guilherme Castro Dabus, M.D., Co-director of Interventional Radiology and Vice-chief of the Department of Neuroscience, Miami Neuroscience Institute

Join Miami Cancer Institute experts, Adrian Cristian, M.D., chief of cancer rehabilitation, and Romer Orada M.D. , a physical medicine and rehabilitation physician, as they discuss the importance of cancer rehabilitation. From initial diagnosis, into survivorship and the end stages of the cancer journey, cancer rehabilitation can play a significant role in improving the quality of life of cancer patients of all ages.

Welcome to the Baptist HealthTalk Doc-to-Doc Podcast, a conversation for physicians by physicians, providing insight on the latest in medical practice, research, technology and innovation in healthcare. Join Baptist Health experts as they offer practical advice for clinicians, covering a wide range of specialties.   Join John Diaz M.D., Chief of Gynecologic Oncology and Starr Mautner M.D., Breast Surgical Oncologist, as they discuss women's health concerns, preventative screenings, surgical approaches, and innovative treatments offered at Miami Cancer Institute. To find out more about the topics covered on the Doc-to-Doc Podcast, please visit physicianresources.baptisthealth.net

Welcome to the Baptist HealthTalk Doc-to-Doc Podcast, a conversation for physicians by physicians, providing insight on the latest in medical practice, research, technology and innovation in healthcare. Join Baptist Health experts as they offer practical advice for clinicians, covering a wide range of specialties. Join Michael McDermott, M.D., neurosurgeon and chief medical executive of Miami Neuroscience Institute and Minesh Mehta, M.D., deputy director and chief of radiation oncology at Miami Cancer Institute as they discuss chordoma, a rare type of cancer that occur in the bones of the skull base and spine. Learn about surgical treatment as well as radiotherapy and other options on this premiere episode.To find out more about the topics covered on the Doc-to-Doc Podcast, please visit physicianresources.baptisthealth.net Related resources: chordomafoundation.org